Forus
Forus is an AI-powered medication access platform that automates prior authorizations, appeals, and pharmacy routing for healthcare providers and patients at no cost, monetizing through pharmaceutical company partnerships and serving thousands of practices across all 50 U.S. states.
- Company typePrivate
- Founded2023
- HeadquartersNew York, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Forus does
Forus is a New York-based healthtech company that operates an AI-powered medication access network automating prior authorizations, appeal letters, enrollment forms, pharmacy routing, benefit verifications, specialty pharmacy calls, PA renewal tracking, affordability programs, and patient communication. The platform is provided at no cost to healthcare providers and patients, with revenue generated from pharmaceutical company partnerships and aggregated life-sciences data insights. Forus serves thousands of medical practices across all 50 U.S. states, spanning solo practitioners, mid-market specialty groups, and large multi-state physician networks in dermatology, gastroenterology, allergy and immunology, rheumatology, neurology, and pulmonology, alongside biopharma customers.
The platform's technical core is a proprietary LLM Judge that verifies generated prior-authorization answers against patient clinical records and specialty-specific guidelines using an atomic-decompose / query-expansion / worst-verdict-aggregation architecture, evaluated through a novel perturbation-based methodology. A RAG-based appeal generator pulls full patient clinical history to produce comprehensive denial-overturn letters. The system is delivered through direct integrations with major EHRs (athenahealth, Epic, eClinicalWorks, ModMed, NextGen, and cloud-based systems) and is fully HIPAA-compliant with SOC 2 Type II certification. Clinical operations are governed by an in-house Clinical Intelligence team led by physicians, including a Head of Clinical Intelligence who previously served as VP of Applied AI at Oscar Health.
Forus monetizes through subscription and data-monetization contracts with five of the top ten global biopharma companies, who gain unique insight into provider friction, patient drop-off, and real-world medicine performance. In May 2026 the company raised a $160 million Series B led by Thrive Capital at a $1 billion post-money valuation, with disclosed annualized revenue above $50 million, and simultaneously rebranded from Tandem to Forus. The company had previously raised over $160 million from the same investor syndicate, employs approximately 100 engineers and operators at its SoHo headquarters, and has grown provider adoption 10x year-over-year for two consecutive years.
Forus firmographics
Firmographics- Name
- Forus
- Legal name
- Forus, Inc.
- Website
- https://forus.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Forus is an AI-powered medication access platform that automates prior authorizations, appeals, and pharmacy routing for healthcare providers and patients at no cost, monetizing through pharmaceutical company partnerships and serving thousands of practices across all 50 U.S. states.
- Ownership category
- akta.pro rank
Forus industry classification
Industry- Product category
- Prior Authorization Automation Software
- NAICS
- Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- ePrescribing Networks, Routing & Provider Enablement (HLACAKAA)
- akta.pro secondary industries
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)
Keywords
Where Forus is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Forus business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Pharmaceutical Company Partnerships: Revenue is generated from pharmaceutical companies who pay for access to Forus' network and medication access platform. Five of the top ten global biopharma companies have partnered with Forus. The platform provides unique insights into where providers get stuck, where patients drop off, and how medicines perform across populations.
- Life Sciences Data & Insights: The network provides unmatched insight into how medicines perform, enabling life sciences companies to design better research, launch new drugs more effectively, and invest in harder-to-treat conditions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free for all providers and patients |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Forus product offering
Product offeringCore offering
Forus operates an AI-powered medication access network that automates prior authorizations, appeal letter generation, pharmacy routing, benefit verification, financial assistance enrollment, and patient communication for healthcare providers. The platform integrates directly with major EHR systems (athenahealth, eClinicalWorks, Epic, ModMed, NextGen, and cloud-based EHRs) to extract patient records, generate and submit prior authorizations, route prescriptions to optimal pharmacies, and track every step from prescription to treatment. It is provided at no cost to providers and patients, with revenue generated from pharmaceutical company partnerships.
Product overview
Forus is a unified AI-powered medication access platform that automates every step from prescription to patient treatment. The core Forus Platform integrates with provider EHR systems to automatically generate and submit prior authorizations, route prescriptions to optimal pharmacies, enroll patients in financial assistance programs, and generate appeal letters when denials occur. Key AI components include an LLM Judge system for verifying clinical claims, a RAG-Based Appeal Generator for producing comprehensive denial responses, and Clinical Intelligence tools for denial prediction and clinical scoring. The platform operates across all drugs, insurance plans, and pharmacies nationwide at no cost to providers or patients, serving thousands of medical practices across all 50 U.S. states.
Differentiator
Problem solved
Functional benefit
Products and services
- Forus Platform AI-powered medication access platform that automates every step from prescription to affordable treatment for healthcare providers. Includes prior authorization automation, appeal letter generation, pharmacy routing, benefit verification, specialty pharmacy calls, PA renewal tracking, affordability program enrollment, and real-time patient communication. Integrates directly with major EHRs (athenahealth, eClinicalWorks, Epic, ModMed, NextGen, plus cloud-based EHRs) to extract patient records, generate and submit prior authorizations, and track every step to treatment. Serves thousands of medical practices across all 50 U.S. states at no cost to providers or patients, with revenue generated from pharmaceutical company partnerships.
Quantifiable outcome
- PA turnaround reduced from 2-4 weeks to 1.7 days average
- +6 more outcomes
Companies that use Forus
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles4 records
Forus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability7 records
Feature5 records
Forus partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- American Gastroenterological Association (AGA)coreStrategic partnership to improve how the more than 60 million Americans living with digestive diseases get the therapies their clinicians prescribe. Pairing AGA's clinical leadership with Forus's medication access platform to strengthen advocacy for patients.
- Top 10 Global Biopharma CompaniesflagshipFive of the top ten global biopharma companies have partnered with Forus. These partnerships provide unique insights into medication access patterns and help life sciences companies design better research, launch new therapies more effectively, and invest in harder-to-treat conditions.
- OpenEvidencecoreStrategic partnership to directly connect evidence-based clinical decision-making with seamless prescription generation and prior authorization submission. Eliminates delays between diagnosis and treatment by integrating OpenEvidence's clinical guidance with Forus's automation.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Forus competitors and assessment
Company assessmentDirect peers
- Cohere Health: AI-driven prior authorization and utilization management platform working with payers and providers; directly comparable in PA automation scope, though with stronger payer-side orientation.
- Surescripts: National ePrescribing network connecting providers, payers, and pharmacies. Closely comparable to Forus's provider-enablement and routing network role across the medication access workflow.
- Infinitus Systems: AI voice/chat agents automating benefit verification, prior authorization, and specialty pharmacy calls for providers; competes directly in the same end-to-end PA workflow.
- Myndshft: Prior authorization workflow automation platform for providers and health systems; comparable in automating eligibility, benefits, and PA submissions.
- CoverMyMeds: Leading electronic prior authorization platform now owned by McKesson; directly competes with Forus in PA automation, appeals, and EHR-integrated medication workflows for providers and pharmacies.
- Humata Health: AI platform focused on prior authorization automation for specialty medications and complex therapies; directly comparable in biologic-heavy PA workflows.
- DrFirst: EHR-integrated ePrescribing, medication history, and clinical messaging platform; competes directly in medication workflow automation and provider-pharmacy connectivity.
Emerging players
- GoodRx: Consumer-facing medication access and affordability platform; adjacent rather than directly competitive, but overlaps with Forus's affordability-program and patient-cost-transparency value proposition.
Broad incumbents
- Olive AI: Healthcare automation AI company addressing revenue cycle, utilization management, and other administrative workflows; broader healthcare AI incumbent with overlapping PA-adjacent capabilities.
- Change Healthcare (Optum): Optum-owned healthcare IT platform with extensive payer-provider data exchange and PA-related capabilities; broad incumbent that overlaps with Forus's network and pharmacy-routing functionality.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Forus social profiles
Digital presenceForus compliance and trust
Trust signalCompliance2 records
Forus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Forus leadership team
Management profileNumber of profiles
Profiles3 records
Forus funding detail
Funding detailFunding overview
Funding rounds4 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Forus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Forus
What does Forus do?
Forus operates an AI-powered medication access network that automates prior authorizations, appeal letter generation, pharmacy routing, benefit verification, financial assistance enrollment, and patient communication for healthcare providers. The platform integrates directly with major EHR systems (athenahealth, eClinicalWorks, Epic, ModMed, NextGen, and cloud-based EHRs) to extract patient records, generate and submit prior authorizations, route prescriptions to optimal pharmacies, and track every step from prescription to treatment. It is provided at no cost to providers and patients, with revenue generated from pharmaceutical company partnerships.
Is Forus a public or private company?
Forus is a private company. It is classified as venture growth investor backed and is currently operating.
When was Forus founded?
Forus was founded in 2023. It employs 101 to 250 people.
Where is Forus based?
Forus is headquartered in New York, United States, in the North America region.
How does Forus make money?
Two revenue lines are on record. Pharmaceutical Company Partnerships are the primary driver. The others are life Sciences Data & Insights.
Who are Forus's main competitors?
Direct peers on record are Cohere Health, Surescripts, Infinitus Systems, Myndshft, CoverMyMeds, Humata Health and DrFirst. GoodRx is listed as an emerging player. Broad incumbents are Olive AI and Change Healthcare (Optum).
Does Forus have an API?
No public API is recorded for Forus.
What industry is Forus in?
Forus's product category is Prior Authorization Automation Software. Its primary akta.pro industry code is HLACAKAA, ePrescribing Networks, Routing & Provider Enablement, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 54151 and its SIC code is 7372.